Kit for screening blood type irregular antibody
A kit and irregular technology, applied in the field of kits for screening irregular blood type antibodies, can solve problems such as delayed transfusion reactions, weak agglutination strength, endangering patients, etc., and achieve reduced clinical blood transfusion risk, good long-term stability, The effect of reducing batch-to-batch variation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] Example 1 Selection of O-type erythrocytes with broad antigen spectrum for 3 persons
[0037] It is composed of O-type red blood cells with suitable antigen spectrum ratio for 3 people. Each person's O-type red blood cells are divided into two branches, one is enzyme-treated red blood cells, and the other is not enzyme-treated red blood cells. Red blood cells for three persons are divided into No. Ⅰ, No. Ⅱ and No. Ⅲ groups. The three groups of red blood cells follow the following requirements:
[0038](1) The red blood cell antigen spectrum should include common clinically significant blood group system antigens (Rh, MNSs, Lewis, Kidd, Duffy, Kell, P). Red blood cells express D, C, c, E, e, Jk a 、Jk b , M, N, S, s, Fy a 、Fy b 、Le a 、Le b , K, k, P 1 and other antigens. D, C, c, E, e, s, Le in red blood cells per person b 、Fy a , K, at least two antigens are positive, M, N, S, Le a 、JK a 、JK b 、Fy b ,P 1 At least one antigen was positive.
[0039] (2) Hom...
Embodiment 2
[0044] Example 2 Effect of Enzyme Treatment Red Blood Cell System Test Conditions on Antibody Screening Test Results
[0045] In this embodiment, the quality control test: using the micro-column gel method, 50 μl of 1% red blood cell suspension treated under different conditions were added to the BIORAD diamed low-ion anti-human globulin card, and the test results were observed after centrifugation. Purpose: To detect whether red blood cells treated with different conditions will cause false positives.
[0046] Specificity test: Using the micro-column gel method, add 50 μl of 1% red blood cell suspension treated under different conditions to the BIORAD diamed low-ion anti-human globulin card, add 12 wells for the same type of cells; add 12 μl of the same type of cells Add commercialized blood group antibodies of known specificity to each well (anti-D, Anti-E, Anti-e, Anti-C, Anti-c, Anti-M, Anti-N purchased from Shanghai Blood, Anti-Jka, Anti-Jkb, Anti-P1, Anti-Lea, Anti-Leb)...
Embodiment 3
[0070] Embodiment 3 The method for determining the concentration of erythrocyte suspension in the erythrocyte detection system of the kit of the present invention
[0071] Randomly select 20 whole blood samples, measure their HCT (hematocrit) after mixing thoroughly, and prepare a red blood cell suspension with a concentration of 1% according to the HCT (hematocrit), and the solvent is normal saline. The hemoglobin content of the erythrocyte suspension was measured by the o-methylbenzidine method, and finally the true concentration of the cell suspension was deduced according to the amount of hemoglobin. The test results are shown in Table 5:
[0072] Table 5 prepares the deviation comparison of 1% erythrocyte suspension for traditional method and recommended method of the present invention
[0073]
[0074] According to the experimental data in the above table, it can be seen that the true concentration of the 1% red blood cell suspension prepared according to the traditi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com